REBECCA DHAWAN: Open Payments
NPI 1689318511 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$955 in 61 payments from 18 companies in 2025. Trend: 2023 $490 · 2024 $724 · 2025 $955
Food & beverage: $865Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $193 |
| Galderma Laboratories, L.P. | 15 | $159 |
| Organon LLC | 8 | $96 |
| PFIZER INC. | 5 | $77 |
| Regeneron Healthcare Solutions, Inc. | 4 | $68 |
| Amgen Inc. | 3 | $51 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $51 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
| Botanix SB Inc | 3 | $48 |
| Arcutis Biotherapeutics, Inc. | 1 | $33 |
Products named: TREMFYA, NEMLUVIO, DUPIXENT, VTAMA, Otezla, ILUMYA, Sotyktu, SOFDRA.
Industry payments across NY — which companies pay providers there.
